Gene Therapy Ready Site Network


Advarra knows gene therapy. Our growing network of Gene Therapy Ready sites are pre-registered, vetted, and standing by to conduct your clinical trial.

Join the Gene Therapy Ready Network

Leverage the world’s largest integrated IRB and IBC service combined with the most comprehensive Gene Therapy Ready site network to move your clinical trials forward—faster.

 

Gene Therapy Ready Sites:

Receive complimentary registration with NIH to have Advarra serve as your IBC of record

Demonstrate expertise and readiness to conduct your trials involving genetically engineered therapies and vaccines

Complete study start-up 5-6 weeks faster than non-GTR sites and 8-12 weeks faster than sites who use a local IBC

Request a Complete List of Gene Therapy Ready Sites

Get GTR List

Is Your Site Ready?

Research into gene therapy-based treatments and mRNA based vaccines is accelerating exponentially. Is your research site ready to take advantage of this growing area of clinical trials?

Become Gene Therapy Ready by having Advarra registered as your IBC!

Turnaround Time

Turnaround can depend on a site’s experience with and preparation for IBC review. Sites that are part of Advarra’s Gene Therapy Ready network have an existing IBC and prior experience with human gene transfer studies. When Advarra is selected as the central IRB and IBC, these sites can often be reviewed and approved for a new gene therapy and mRNA vaccine research study in just a few days.